GlobalOne Healthcare Holding

GlobalOne Healthcare Holding is the healthcare division of Yas Holding in the United Arab Emirates and operates as a healthcare-focused investment and operating holding company. The group has built a portfolio spanning biopharma, pharmaceutical manufacturing, hospital management, healthcare consultancy, medical supply chain, and occupational health. Its subsidiaries have included Bioventure, Bioventure Healthcare, Gulf Inject, Wellpharma, Global Medical Supply Chain, and Al Ittihad Drug Store, although several of these assets were sold to Mubadala-linked entities in 2024-2026. Through Bioventure, the group has been active in biosimilars, specialty generics, tech transfer, and regional licensing partnerships in the Middle East and Africa. Overall, GlobalOne Healthcare Holding appears to be a commercial-stage healthcare platform centered on regional healthcare infrastructure, pharmaceutical commercialization, and manufacturing capabilities rather than a single R&D-driven drug developer.